Company / Cash & Equivalents
NU SKIN ENTERPRISES, INC. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$238.6M
FY2025
5-year range
$186.9M / $339.6M
FY2021-FY2025
Trend
+27.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents returned to growth in FY2025 after 4 years of decline, reaching $239M.
Based on SEC 10-K filings.
$239M in FY2025 with a 5-year CAGR of -9.9%.
Declined from $256M to $239M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -3.4%
- 5-Year CAGR
- -9.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -9.9%, indicating a declining trend.
- In FY2025, cash & equivalents increased 27.7% year-over-year.
- Peak cash & equivalents was recorded in FY2018.
- Lowest cash & equivalents in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $238.6M | +27.7% |
| FY2024 | $186.9M | -27.0% |
| FY2023 | $256.1M | -3.3% |
| FY2022 | $264.7M | -22.0% |
| FY2021 | $339.6M | -15.7% |
| FY2020 | $402.7M | +20.0% |
| FY2019 | $335.6M | -21.3% |
| FY2018 | $426.4M | +47.4% |
| FY2017 | $289.4M | +0.3% |
| FY2016 | $288.4M | -45.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026